Igene Biotechnology, Inc.
IGNE · OTC
9/30/2010 | 6/30/2010 | 3/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $269 | $977 | $1,276 | $1,295 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2,172 | $1,994 | $2,279 | $2,320 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $2,442 | $2,983 | $3,588 | $3,660 |
| Property Plant & Equip (Net) | $747 | $785 | $815 | $853 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $150 | $150 | $150 | $150 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $74 | $82 | $90 | $98 |
| Total NC Assets | $971 | $1,016 | $1,055 | $1,100 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,413 | $3,999 | $4,643 | $4,760 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $1,613 | $1,613 | $1,488 | $1,095 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $517 | $488 | $452 | $465 |
| Total Curr. Liab. | $2,130 | $2,100 | $1,939 | $1,560 |
| LT Debt | $5,723 | $5,716 | $5,709 | $5,702 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $246 | $244 | $242 | $240 |
| Total NC Liab. | $5,969 | $5,960 | $5,951 | $5,942 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $8,099 | $8,060 | $7,891 | $7,502 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $15,654 | $15,654 | $15,654 | $15,604 |
| Retained Earnings | -$54,859 | -$54,232 | -$53,421 | -$52,872 |
| AOCI | $52 | $50 | $52 | $58 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$4,686 | -$4,061 | -$3,248 | -$2,743 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,413 | $3,999 | $4,643 | $4,760 |
| Net Debt | $7,066 | $6,351 | $5,921 | $5,501 |